EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes

Xinyu Li, Louise A Donnelly, Roderick C Slieker, Joline W J Beulens, Leen M 't Hart, Petra J M Elders, Ewan R Pearson, Anoukh van Giessen, Jose Leal, Talitha Feenstra

Diabetologia · 2024-07 · 67 (7) · 1343-1355

DOI: 10.1007/s00125-024-06147-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, online erschienen am 16.04.2024. Verfasst von Xinyu Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, the Netherlands. li.xinyu@rug.nl. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis This study aimed to explore the added value of subgroups that categorise individuals with type 2 diabetes by k -means clustering for two primary care registries (the Netherlands and Scotland), inspired by Ahlqvist’s novel diabetes subgroups and previously analysed by Slieker et al.

Methods

We used two Dutch and Scottish diabetes cohorts ( N =3054 and 6145; median follow-up=11.2 and 12.3 years, respectively) and defined five subgroups by k -means clustering with age at baseline, BMI, HbA 1c , HDL-cholesterol and C-peptide. We investigated differences between subgroups by trajectories of risk factor values (random intercept models), time to diabetes-related complications (logrank tests and Cox models) and medication patterns (multinomial logistic models). We also compared directly using the clustering indicators as predictors of progression vs the k -means discrete subgroups. Cluster consistency over follow-up was assessed.

Results

Subgroups’ risk factors were significantly different, and these differences remained generally consistent over follow-up. Among all subgroups, individuals with severe insulin resistance faced a significantly higher risk of myocardial infarction both before (HR 1.65; 95% CI 1.40, 1.94) and after adjusting for age effect (HR 1.72; 95% CI 1.46, 2.02) compared with mild diabetes with high HDL-cholesterol. Individuals with severe insulin-deficient diabetes were most intensively treated, with more than 25% prescribed insulin at 10 years of diagnosis. For severe insulin-deficient diabetes relative to mild diabetes, the relative risks for using insulin relative to no common treatment would be expected to increase by a factor of 3.07 (95% CI 2.73, 3.44), holding other factors constant. Clustering indicators were better predictors of progression variation relative to subgroups, but prediction accuracy may improve after combining both. Clusters were consistent over 8 years with an accuracy ranging from 59% to 72%. Conclusions/interpretation Data-driven subgroup allocations were generally consistent over follow-up and captured significant differences in risk factor trajectories, medication patterns and complication risks. Subgroups serve better as a complement rather than as a basis for compressing clustering indicators. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HumansMaleFemaleMiddle AgedAgedRisk FactorsNetherlandsGlycated HemoglobinScotlandCholesterol, HDLRegistriesC-PeptideDisease ProgressionAdultCluster AnalysisInsulin ResistanceBody Mass Index

Stichwörter der Autor:innen

Data-driven subgroupsLongitudinal analysisReal-world dataRoutine careStratification of diabetes

Substanzen

Glycated HemoglobinCholesterol, HDLC-Peptide

Autor:innen und Institutionen

  • Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, the Netherlands. li.xinyu@rug.nl.
  • Division of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee, UK.
  • Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Epidemiology and Data Science, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Amsterdam Public Health, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

Förderung

  • Horizon 2020 Framework Programme

Zitieren

APA

Li, X., Donnelly, L. A., Slieker, R. C., Beulens, J. W. J., 't Hart, L. M., Elders, P. J. M., Pearson, E. R., van Giessen, A., Leal, J., & Feenstra, T. (2024). Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes. Diabetologia, 67(7), 1343-1355. https://doi.org/10.1007/s00125-024-06147-y

Vancouver

Li X, Donnelly LA, Slieker RC, Beulens JWJ, 't Hart LM, Elders PJM, et al. Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes. Diabetologia. 2024;67(7):1343-1355. doi:10.1007/s00125-024-06147-y

BibTeX
@article{Li2024,
  author = {Li, Xinyu and Donnelly, Louise A and Slieker, Roderick C and Beulens, Joline W J and 't Hart, Leen M and Elders, Petra J M and Pearson, Ewan R and van Giessen, Anoukh and Leal, Jose and Feenstra, Talitha},
  title = {Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes},
  journal = {Diabetologia},
  year = {2024},
  volume = {67},
  number = {7},
  pages = {1343--1355},
  doi = {10.1007/s00125-024-06147-y}
}
Kostenlos starten →